ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 300 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $47,000 | -13.0% | 1,148 | +1.2% | 0.01% | -25.0% |
| Q2 2020 | $54,000 | +12.5% | 1,134 | 0.0% | 0.01% | -20.0% |
| Q1 2020 | $48,000 | -2.0% | 1,134 | 0.0% | 0.01% | +11.1% |
| Q4 2019 | $49,000 | +22.5% | 1,134 | 0.0% | 0.01% | +12.5% |
| Q3 2019 | $40,000 | +33.3% | 1,134 | 0.0% | 0.01% | +33.3% |
| Q2 2019 | $30,000 | -86.2% | 1,134 | -86.1% | 0.01% | -86.7% |
| Q1 2019 | $218,000 | +66.4% | 8,134 | 0.0% | 0.04% | +40.6% |
| Q4 2018 | $131,000 | -43.3% | 8,134 | -26.9% | 0.03% | -25.6% |
| Q3 2018 | $231,000 | +29.1% | 11,134 | -5.5% | 0.04% | +19.4% |
| Q2 2018 | $179,000 | -31.2% | 11,784 | +71.2% | 0.04% | -57.1% |
| Q3 2017 | $260,000 | +28.7% | 6,884 | +10.4% | 0.08% | +9.1% |
| Q1 2017 | $202,000 | – | 6,234 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |